← 產業報告目錄
AI-assisted Peptide Drug Discovery Platform Market, Share & Trends Analysis Report, By Application (Drug Design and Optimization, Hit Identification and Lead Generation, Target Validation, Preclinical Validation), By Therapeutic Area (Metabolic Disorders, Oncology, Infectious Diseases, Neurological Disorders, Inflammatory and Autoimmune Diseases, Other Areas), By Technology (Machine Learning, Deep Learning, Generative AI, Natural Language Processing, Reinforcement Learning), By End-User, Platform Access Model, By Region, and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-03-17頁數 170報告編號 INSIGHTACE-38248df745
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide AI-assisted Peptide Drug Discovery Platform Market is anticipated to register a CAGR of 14.1%.
AI-assisted Peptide Drug Discovery Platform encompasses a technology-driven system that integrates artificial intelligence (ai) with peptide chemistry, bioinformatics, and structural biology to accelerate a. The sector has gained traction as organizations seek innovative approaches to address evolving technology and communications challenges.
Market momentum is propelled by mounting appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-assisted Peptide Drug Discovery Platform Market Snapshot
Chapter 4. Global AI-assisted Peptide Drug Discovery Platform Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on AI-assisted Peptide Drug Discovery Platform Market Industry Trends
4.10. Global AI-assisted Peptide Drug Discovery Platform Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI-assisted Peptide Drug Discovery Platform Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
5.2.1. Drug Design and Optimization
5.2.2. Hit Identification and Lead Generation
5.2.3. Target Validation
5.2.4. Preclinical Validation
Chapter 6. AI-assisted Peptide Drug Discovery Platform Market Segmentation 2: By Therapeutic Area, Estimates & Trend Analysis
6.1. Market Share by Therapeutic Area, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Area:
6.2.1. Metabolic Disorders
6.2.2. Oncology
6.2.3. Infectious Diseases
6.2.4. Neurological Disorders
6.2.5. Inflammatory and Autoimmune Diseases
6.2.6. Other Areas
Chapter 7. AI-assisted Peptide Drug Discovery Platform Market Segmentation 3: By End-User Industry, Estimates & Trend Analysis
7.1. Market Share by End-User Industry, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User Industry:
7.2.1. Pharmaceutical and Biotechnology Companies
7.2.2. Contract Research Organizations
7.2.3. Academic and Research Institutions
7.2.4. Startups and SMEs
Chapter 8. AI-assisted Peptide Drug Discovery Platform Market Segmentation 4: By Technology, Estimates & Trend Analysis
8.1. Market Share by Technology, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
8.2.1. Machine Learning
8.2.2. Deep Learning
8.2.3. Generative AI
8.2.4. Natural Language Processing
8.2.5. Reinforcement Learning
Chapter 9. AI-assisted Peptide Drug Discovery Platform Market Segmentation 5: By Platform Access Model, Estimates & Trend Analysis
9.1. Market Share by Platform Access Model, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Platform Access Model:
9.2.1. Pipeline Licensing
9.2.2. Technology Licensing
9.2.3. Strategic Alliances
9.2.4. Library Provider
9.2.5. Service Provider
Chapter 10. AI-assisted Peptide Drug Discovery Platform Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global AI-assisted Peptide Drug Discovery Platform Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.3. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
10.2.4. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.2.5. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.2.6. North America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Access Model, 2021-2034
10.3. Europe
10.3.1. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.3. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
10.3.4. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.3.5. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.3.6. Europe AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Access Model, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.3. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
10.4.4. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.4.5. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts Technology, 2021-2034
10.4.6. Asia Pacific AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Access Model, 2021-2034
10.5. Latin America
10.5.1. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.3. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
10.5.4. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.5.5. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.5.6. Latin America AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Access Model, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.3. Middle East & Africa AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
10.6.4. Middle East & Africa AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by End-User Industry, 2021-2034
10.6.5. Middle East & Africa AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.6.6. Middle East & Africa AI-assisted Peptide Drug Discovery Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Access Model, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Peptilogics
11.2.1.1. Business Overview
11.2.1.2. Key Application/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Pepticom
11.2.3. Gubra
11.2.4. Nuritas
11.2.5. Aurigene
11.2.6. Space Peptides
11.2.7. Koliber Biosciences
11.2.8. Cradle
11.2.9. Insilico Medicine
11.2.10. Fujitsu
11.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們